In addition, breast cancer in postmenopausal women is significantly associated with the immune-recognised (IgA-positive) and -unrecognised (IgA-negative) gut microbiota, the former possibly through immune-mediated pathways and the latter possibly through the enterohepatic circulation effects of estrogen (117). Here, CD79A is linked to breast carcinoma.